Drug Trial Radar · NCT02085408
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Last checked: Nov 20, 2026Latest source record: Dec 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
727
Actual
Start
Feb 4, 2011
Primary completion
Feb 22, 2021
Study completion Dec 21, 2022
Sponsor
- Lead sponsor
- ECOG-ACRIN Cancer Research GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Mar 12, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase III trial studies clofarabine to see how well it works compared with daunorubicin hydrochloride and cytarabine when followed by decitabine or observation in treating older patients with newly diagnosed acute myeloid leukemia. Drugs used in chemotherapy, such as clofarabine, daunorubicin hydrochloride, cytarabine, and decitabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. It is not yet known which chemotherapy regimen is more effective in treating acute myeloid leukemia.
Conditions
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- Adult Acute Megakaryoblastic Leukemia (M7)
- Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
- Adult Acute Monoblastic Leukemia (M5a)
- Adult Acute Monocytic Leukemia (M5b)
- Adult Acute Myeloblastic Leukemia With Maturation (M2)
- Adult Acute Myeloblastic Leukemia Without Maturation (M1)
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- Adult Acute Myeloid Leukemia With Del(5q)
- Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
- Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
- Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
- Adult Acute Myelomonocytic Leukemia (M4)
- Adult Erythroleukemia (M6a)
- Adult Pure Erythroid Leukemia (M6b)
- Secondary Acute Myeloid Leukemia
- Untreated Adult Acute Myeloid Leukemia
Interventions
DaunorubicinDrug
Given IV
CytarabineDrug
Given IV
ClofarabineDrug
Given IV
DecitabineDrug
Given IV
ObservationOther
Undergo clinical observation
Allogeneic hematopoietic stem cell transplantationProcedure
Patients with an HLA-identical donor proceed to allogeneic stem cell transplantation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: Assessed every 3 months for 4 years and then every 6 months for 1 year
Locations
269 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Mayo Clinic in Arizona
Scottsdale, Arizona
Arizona Cancer Center at University Medical Center North
Tucson, Arizona
University of Arizona Health Sciences Center
Tucson, Arizona
The Medical Center of Aurora
Aurora, Colorado
Boulder Community Hospital
Boulder, Colorado
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado
Saint Anthony Central Hospital
Denver, Colorado
Porter Adventist Hospital
Denver, Colorado
Exempla Saint Joseph Hospital
Denver, Colorado
Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado
Rose Medical Center
Denver, Colorado
Colorado Cancer Research Program CCOP
Denver, Colorado
Swedish Medical Center
Englewood, Colorado
North Colorado Medical Center
Greeley, Colorado
Littleton Adventist Hospital
Littleton, Colorado
Sky Ridge Medical Center
Lone Tree, Colorado
Longmont United Hospital
Longmont, Colorado
McKee Medical Center
Loveland, Colorado
Parker Adventist Hospital
Parker, Colorado
Saint Mary Corwin Medical Center
Pueblo, Colorado
North Suburban Medical Center
Thornton, Colorado
Exempla Lutheran Medical Center
Wheat Ridge, Colorado
Saint Francis Hospital and Medical Center
Hartford, Connecticut
The Hospital of Central Connecticut
New Britain, Connecticut
Beebe Medical Center
Lewes, Delaware
Christiana Care Health System-Christiana Hospital
Newark, Delaware
University of Florida
Gainesville, Florida
Mayo Clinic in Florida
Jacksonville, Florida
Florida Hospital
Orlando, Florida
Piedmont Hospital
Atlanta, Georgia
Atlanta Regional CCOP
Atlanta, Georgia
Northside Hospital
Atlanta, Georgia
Saint Joseph's Hospital of Atlanta
Atlanta, Georgia
Georgia Regents University
Augusta, Georgia
Well Star Cobb Hospital
Austell, Georgia
John B Amos Cancer Center
Columbus, Georgia
Dekalb Medical Center
Decatur, Georgia
Piedmont Fayette Hospital
Fayetteville, Georgia
Gwinnett Medical Center
Lawrenceville, Georgia
Showing 40 of 269 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.